Roger Seheult, MD of MedCram explores a new randomized controlled trial that shows a 48% reduction in mortality in severe communityacquired pneumonia when patients receive intravenous hydrocortisone. See all Dr. Seheult's videos at: https://www.medcram.com/?utm_source=Y...'>https://www.medcram.com/?utm_source=Y...

(This video was recorded on March 26, 2023)

Roger Seheult, MD is the cofounder and lead professor at https://www.medcram.com/?utm_source=Y...'>https://www.medcram.com/?utm_source=Y...

He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


LINKS / REFERENCES:

Hydrocortisone in Severe CommunityAcquired Pneumonia (NEJM) | https://www.nejm.org/doi/10.1056/NEJM...

PSI/PORT Score: Pneumonia Severity Index for CAP (MDCalc) | https://www.mdcalc.com/calc/33/psipo...

Pneumonia Explained Clearly (MedCram) | https://www.medcram.com/courses/pneum...


SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:

https://www.youtube.com/user/MEDCRAMv...
Get notified of new videos by hitting the bell icon

MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at [email protected] if you are interested.


MEDIA CONTACT:

Media Contact: [email protected]
Media contact info: https://www.medcram.com/pages/mediac...

Video Produced by Kyle Allred


FOLLOW US ON SOCIAL MEDIA:

  / medcram  
  / medcramvideos  
  / medcram  


DISCLAIMER:

MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

#hydrocortisone #pneumonia #RCT